- Home
- NBTX vs BTMD Comparison
NBTX vs BTMD Comparison
Compare NBTX & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- BTMD
- Stock Information
- Founded
- NBTX 2003
- BTMD 2012
- Country
- NBTX France
- BTMD United States
- Employees
- NBTX N/A
- BTMD N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- NBTX Health Care
- BTMD Health Care
- Exchange
- NBTX Nasdaq
- BTMD Nasdaq
- Market Cap
- NBTX 201.9M
- BTMD 224.1M
- IPO Year
- NBTX 2020
- BTMD N/A
- Fundamental
- Price
- NBTX $3.83
- BTMD $6.14
- Analyst Decision
- NBTX Strong Buy
- BTMD Strong Buy
- Analyst Count
- NBTX 2
- BTMD 4
- Target Price
- NBTX $11.50
- BTMD $8.39
- AVG Volume (30 Days)
- NBTX 8.8K
- BTMD 171.5K
- Earning Date
- NBTX 11-26-2024
- BTMD 11-12-2024
- Dividend Yield
- NBTX N/A
- BTMD N/A
- EPS Growth
- NBTX N/A
- BTMD N/A
- EPS
- NBTX N/A
- BTMD 0.21
- Revenue
- NBTX $45,220,186.00
- BTMD $193,060,000.00
- Revenue This Year
- NBTX N/A
- BTMD $11.06
- Revenue Next Year
- NBTX N/A
- BTMD $14.82
- P/E Ratio
- NBTX N/A
- BTMD $28.04
- Revenue Growth
- NBTX 526.17
- BTMD 4.84
- 52 Week Low
- NBTX $3.57
- BTMD $3.65
- 52 Week High
- NBTX $8.96
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- NBTX 38.67
- BTMD 56.61
- Support Level
- NBTX $3.57
- BTMD $5.26
- Resistance Level
- NBTX $4.11
- BTMD $6.89
- Average True Range (ATR)
- NBTX 0.28
- BTMD 0.46
- MACD
- NBTX -0.00
- BTMD 0.06
- Stochastic Oscillator
- NBTX 26.31
- BTMD 57.63
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.